SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
9597349
Source:
http://linkedlifedata.com/resource/pubmed/id/9597349
Search
Subject
(
49
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003289
,
umls-concept:C0010762
,
umls-concept:C0049506
,
umls-concept:C0068485
,
umls-concept:C0078569
,
umls-concept:C0205234
pubmed:dateCreated
1998-8-4
pubmed:abstractText
This review critically evaluates recent information on the cytochrome P450 system, with an emphasis on drug interactions involving antidepressant medications, particularly venlafaxine, nefazodone, and mirtazapine.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/MH-51761
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9708816
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents...
,
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, Tricyclic
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclohexanols
,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 Enzyme System
,
http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes
,
http://linkedlifedata.com/resource/pubmed/chemical/Mianserin
,
http://linkedlifedata.com/resource/pubmed/chemical/Triazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/mirtazapine
,
http://linkedlifedata.com/resource/pubmed/chemical/nefazodone
,
http://linkedlifedata.com/resource/pubmed/chemical/venlafaxine
pubmed:status
MEDLINE
pubmed:issn
1091-4269
pubmed:author
pubmed-author:NemeroffC BCB
,
pubmed-author:OwenJ RJR
pubmed:issnType
Print
pubmed:volume
7 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
24-32
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:9597349-Antidepressive Agents, Second-Generation
,
pubmed-meshheading:9597349-Antidepressive Agents, Tricyclic
,
pubmed-meshheading:9597349-Cyclohexanols
,
pubmed-meshheading:9597349-Cytochrome P-450 Enzyme System
,
pubmed-meshheading:9597349-Depressive Disorder
,
pubmed-meshheading:9597349-Humans
,
pubmed-meshheading:9597349-Isoenzymes
,
pubmed-meshheading:9597349-Mianserin
,
pubmed-meshheading:9597349-Risk Factors
,
pubmed-meshheading:9597349-Triazoles
pubmed:year
1998
pubmed:articleTitle
New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine.
pubmed:affiliation
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.
,
Review